PPT-Hemophilia

H aemophilia By Morgan Dirienzo The Royal Disease Alternate Names and Symptoms Some alternate names for Hemophilia would be Haemorrhaphilia or Von Willebrand disease The Symptoms for Hemophilia are. Hemophilia. X-linked . recessive disorder . characterized by the inability . to properly . form blood clots. .. Until recently, hemophilia was untreatable, and only a few hemophiliacs survived to reproductive age because any small cut or internal hemorrhaging after even a minor bruise were fatal.. 1. Hemophilia A and B: . Disease Differences and the . Use of Prophylactic Therapy. Anna Chalmers, MD . Rush University Medical Center, Chicago, Illinois. A REPORT FROM THE 65. TH. ANNUAL MEETING OF THE NATIONAL HEMOPHILIA FOUNDATION (NHF 2013) . Introduction. What is Hemophilia?. Get Supplies Ready. Mix Your Factor. Find a Vein. Infuse. Clean . Up a Record Keeping. Summary of Hemophilia. 1. Expanding Therapeutic Options . for Hemophilia A and B: . Results of Recent Clinical Trials . Holleh D. Husseinzadeh, MD . Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. A REPORT FROM THE 65. February 4. th. , 2011. The Child With Pain. Single Joint Involvement. Multiple Joint Involvement. With Fever. Septic arthritis/Osteomyelitis. Sympathetic arthritis. Foreign body with infection. Traumatic arthritis. Recognition and Management of Patients with Hemophilia/von . Willebrand. Disease and Platelet Disorders. Rebecca Schaffer, DDS. Assistant Professor, Special Needs Care Unit. Associate Administrative Director, AEGD. organization that assists and advocates for the bleeding disorders community.. MISSION. [Your Name]. [Your Address]. First Responders . &. Hemophilia. © 2015 Hemophilia Federation of America. All rights reserved.. Chemical Basis for Catalytic Activity. Enzymes promote . transition state. (. TS. ).. Transition state favored by tight binding. .. Figure depicts anti-CCR-5 “protease”.. Strategy. : Raise against TS analogs.. More Than Factor Replacement Prescription. IDG. . Ugrasena. Hematology-oncology division . Child Health . Departement. of Dr. . Soetomo. Hospital - Faculty of Medicine . Airlangga. University. Gen D. Introduction/Overview. Introduction/Overview (cont). Importance of Prophylaxis, and Limitations on Its Application, in Hemophilia B. Key Unmet Need in Hemophilia B:. Reducing Patient Burden of Disease. By: Nam-Y7. Hemophilia was first recognized by the Jews, but not officially named even in the ancient times. . In the 2. nd. century AD, the Talmud, a Jewish collection of Rabbinical writings said that the boys did not have to be circumcised if two brothers died of the disease. In 1800s, it became known as the Royal Disease because many people of royal families died or got the disease. Queen Victoria got Hemophilia but she survived. Alexei, the heir apparent to the Russian royal family, suffered from Hemophilia. In 1950s, the first treatment to hemophilia appeared. It was in a type called “fresh frozen plasma”. Nowadays, we are marching towards a cure but there are two treatments. One is called “gene therapy” and the other is called “Recombinant therapy”. A treatment for hemophilia is replacing old blood clots with new ones.. . Peterson, Owen Comer, Quaevon Anderson, and Grace Hodges. Basic Information . Grace. . Hemophilia A. Classic hemophilia. Factor VIII deficiency. Hemophilia B. Christmas disease. Factor IX deficiency. Hemophilia A. Also known as Factor VIII Deficiency is the most common type of hemophilia. It is a disorder of your blood-clotting system. Clotting is the process which your blood changes from a liquid to a solid state. Veena Choubey, Rena Malik, and Luis Carlos Zapata Genetics Hemophilia is an X-linked recessive disorder that exists in two forms, hemophilia A and hemophilia B. Hemophilia A is characterized specif